Skip to main content
OpenTrials
Completed

NCT Number: NCT03823105

Validation of Non-invasive Miniature Optical Sensors for Scoring Sleep Stages

Validation of two devices with optical sensor in healthy participants and patients with sleep wake disorders.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Bern (Inselspital), Department of Pulmonary Medicine

Bern, 3010, Switzerland

About this study

The objective of this study is to evaluate and optimize a method of detecting sleep and sleep stages based on a new algorithm combining actigraphy and heart rate variability (measured by optical analysis of the pulse wave) to determine sleep architecture (segmented into three phases: WAKE, REM and NREM) with high accuracy compared to the gold standard polysomnography.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Patients with sleep wake disorders

Inclusion criteria

  • 18 ≤ Age ≤ 80 years
  • Suspected sleep wake disorder (sleep apnea, sleep movement disorders, hypersomnia, parasomnia)
  • Written informed consent

Exclusion criteria

  • Skin condition with eczema or damaged skin
  • Ischemia (cutaneous)
  • Allergy against nickel
  • Allergy against silicone
  • Current treatment with vasoactive drugs (e.g. beta-blockers, calcium channel antagonists, nitroglycerin, etc.) and/or antidepressive drugs (e.g. serotonin reuptake inhibitors, etc.).
  • Known infection with multiresistant bacteria
  • Implanted devices (e.g. pacemaker, pumps)
  • Rhythmogenic heart disease (e.g. resting heart rate > 120/min)
  • Severe or untreated arterial hypertension (blood pressure > 140mmHg systolic, >90mmHg diastolic)
  • Hypotension (blood pressure < 90mmHg systolic, < 60 mmHg diastolic)
  • Current alcohol or drug abuse, alcohol consumption the same day as the study
  • Consumption of coffee 7h before
  • Dark skin pigmentation
  • Severe metabolic disease (e.g. diabetes)
  • Pregnancy or lactation
  • Physical handicap effecting the two arms
  • Wound in the wrist region
  • Too large or too small wrist

Healthy subjects

Inclusion criteria

  • 18 ≤ Age ≤ 80 years
  • Written informed consent

Exclusion criteria

  • Skin condition with eczema or damaged skin
  • Ischemia (cutaneous)
  • Allergy against nickel
  • Allergy against silicone
  • Any Medication (except birth control pill)
  • Known infection with multiresistant bacteria
  • Implanted devices (e.g. pacemaker, pumps)
  • Rhythmogenic heart disease (e.g. resting heart rate > 120/min)
  • Severe or untreated arterial hypertension (blood pressure > 140mmHg systolic, >90mmHg diastolic)
  • Hypotension (blood pressure < 90mmHg systolic, < 60 mmHg diastolic)
  • Current alcohol or drug abuse, alcohol consumption the same day as the study
  • Consumption of coffee 7h before
  • Implanted devices (e.g. pacemaker, pumps)
  • Known sleep-wake disorders
  • Dark skin pigmentation
  • Severe metabolic disease (e.g. diabetes)
  • Pregnancy or lactation
  • Physical handicap effecting the two arms
  • Wound in the wrist region
  • Too large or too small wrist

Treatment and study plan

OHR Tracker and PulseWatch

Device

Category A (ClinO). Medical study with CE-marked medical devices to photoplethysmographic measure heart rate, heart rate variability, and pulse wave and accelerometric data

Primary outcomes

  1. Total Sleep Time (TST) and sleep architecture (distribution of sleep stages)

    Time frame: 1 night

    Diagnostic accuracy of the new algorithm compared to the Gold Standard full polysomnography

  2. The total time in non-REM sleep (stages 1-3), REM sleep, and awake after sleep onset

    Time frame: 1 night

    Diagnostic accuracy of the new algorithm compared to the Gold Standard full polysomnography

Sponsors and collaborators

Lead sponsor

Insel Gruppe AG, University Hospital Bern

Other

Collaborators

  • CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement
  • University of Bern

Registry information

Official study title

Validation of Non-invasive Miniature Optical Sensors for Scoring Sleep Stages: a Prospective, Method-comparison, Proof of Concept, Single-centre Phase IV Study

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Jan 30, 2019
Registry last updated
Jun 11, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.